[go: up one dir, main page]

NO20055485L - Vannloselige salter av risperidon - Google Patents

Vannloselige salter av risperidon

Info

Publication number
NO20055485L
NO20055485L NO20055485A NO20055485A NO20055485L NO 20055485 L NO20055485 L NO 20055485L NO 20055485 A NO20055485 A NO 20055485A NO 20055485 A NO20055485 A NO 20055485A NO 20055485 L NO20055485 L NO 20055485L
Authority
NO
Norway
Prior art keywords
risperidone
water
salt
soluble salts
soluble
Prior art date
Application number
NO20055485A
Other languages
English (en)
Other versions
NO20055485D0 (no
Inventor
Reinerus Gerardus Gieling
Desiree Laurant
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of NO20055485D0 publication Critical patent/NO20055485D0/no
Publication of NO20055485L publication Critical patent/NO20055485L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Oppfirmelsen vedrører et salt av risperidon i fast form med en varmløselighet på minst 10 mg/ml til risperidon dihydroklorid, risperidon hydrogenmaleat, risperidon hemitartrat og risperidon (L)-hemimalat, til en fremgangsmåte for fremstilling av et fastformig vannløselig salt av risperidon, hvilket omfatter: å bringe en risperidondonor i kontakt med en passende syre i en organisk løsningsmiddel, for å danne et vannløselig risperidonsalt, og for å presipitere nevnte risperidonsalt fra nevnte løsningsmiddel og for anvendelse for å behandle psykotiske forstyrrelser i et pattedyr.
NO20055485A 2003-04-22 2005-11-21 Vannloselige salter av risperidon NO20055485L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46436403P 2003-04-22 2003-04-22
PCT/EP2004/004128 WO2004094414A1 (en) 2003-04-22 2004-04-15 Water soluble salts of risperidone

Publications (2)

Publication Number Publication Date
NO20055485D0 NO20055485D0 (no) 2005-11-21
NO20055485L true NO20055485L (no) 2006-01-23

Family

ID=33310877

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20055490A NO20055490L (no) 2003-04-22 2005-11-21 Risperidon monohydroklorid
NO20055485A NO20055485L (no) 2003-04-22 2005-11-21 Vannloselige salter av risperidon

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20055490A NO20055490L (no) 2003-04-22 2005-11-21 Risperidon monohydroklorid

Country Status (5)

Country Link
US (2) US20040266791A1 (no)
EP (2) EP1615923A1 (no)
AR (2) AR044055A1 (no)
NO (2) NO20055490L (no)
WO (2) WO2004094414A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
PL1708790T3 (pl) * 2003-12-02 2010-10-29 Pharmaneuroboost N V Zastosowanie pipamperonu oraz antagonisty receptora D2 lub antagonisty receptora serotoniny/dopaminy do leczenia zaburzeń psychotycznych
US7884096B2 (en) * 2003-12-02 2011-02-08 Pharmaneuroboost N.V. Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
EP1695973A1 (en) * 2005-02-24 2006-08-30 Neuro3D Ocaperidone salt and pharmaceutical compositions containing the same
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
MX337286B (es) 2007-05-25 2016-02-22 Indivior Uk Ltd Formulaciones de transferencia sostenida de compuestos de risperidona.
WO2010105093A2 (en) * 2009-03-12 2010-09-16 Delpor, Inc. Implantable device for long-term delivery of drugs
HUE032310T2 (hu) 2011-04-25 2017-09-28 Shandong luye pharmaceutical co ltd Nyújtott risperidon-leadású mikrogömb kompozíció
WO2012147035A1 (en) 2011-04-26 2012-11-01 Torrent Pharmaceuticals Limited Acid addition salts of risperidone and pharmaceutical compositions thereof
CA2903769A1 (en) 2013-03-11 2014-10-09 Durect Corporation Injectable controlled release composition comprising high viscosity liquid carrier
WO2016149561A1 (en) * 2015-03-17 2016-09-22 Oak Crest Institute Of Science Subdermal implants for the sustained delivery of water-soluble drugs
TW202313047A (zh) 2021-09-21 2023-04-01 西班牙商禾霏藥品實驗室有限公司 抗精神病可注射儲積型組合物
AU2023281232A1 (en) 2022-05-18 2024-10-24 Laboratorios Farmacéuticos Rovi, S.A. Prolonged-release injectable compositions for use in treatment with risperidone together with cyp2d6 enzyme inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
US4342870A (en) * 1980-03-28 1982-08-03 Janssen Pharmaceutica N.V. Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives
US4443451A (en) * 1981-07-15 1984-04-17 Janssen Pharmaceutica N.V. Bicyclic pyrimidin-5-one derivatives
US4485107A (en) * 1982-11-01 1984-11-27 Janssen Pharmaceutica N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US5158952A (en) * 1988-11-07 1992-10-27 Janssen Pharmaceutica N.V. 3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use
GB9008850D0 (en) * 1990-04-19 1990-06-13 Janssen Pharmaceutica Nv Novel 2,9-disubstituted-4h-pyridol(1,2-a)pyrimidin-4-ones
TW376319B (en) * 1993-04-28 1999-12-11 Janssen Pharmaceutica Nv Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
US5453425A (en) * 1994-07-11 1995-09-26 Janssen Pharmaceutica N.V. Risperidone oral formulation

Also Published As

Publication number Publication date
AR044055A1 (es) 2005-08-24
EP1615924A1 (en) 2006-01-18
NO20055490L (no) 2006-01-23
AR044054A1 (es) 2005-08-24
WO2004094415A1 (en) 2004-11-04
NO20055485D0 (no) 2005-11-21
US20040266791A1 (en) 2004-12-30
EP1615923A1 (en) 2006-01-18
US20040266790A1 (en) 2004-12-30
WO2004094414A1 (en) 2004-11-04
NO20055490D0 (no) 2005-11-21

Similar Documents

Publication Publication Date Title
NO20055485L (no) Vannloselige salter av risperidon
NO20076659L (no) Pyrrolo(2,3-B)pyridinderivater som protein kinase inhibitorer
NO20056030L (no) Nye pyridopyraziner og anvendelse derav som kinaseinhibitorer
MXPA05013904A (es) Derivados de pirido[2,1-a] isoquinolinas como inhibidores de dipeptidil-peptidasa iv(dpp-iv).
TW200616994A (en) Novel thiophene derivatives
TW200519111A (en) N3-substituted imidazopyridine C-KIT inhibitors
NO20071290L (no) Enantiomert rene aminoheteroarylforbindelser som protein kinase inhibitorer
EP1180518A4 (en) 5-PYRIDYLE-1,3-AZOLE COMPOUNDS, THEIR MANUFACTURING PROCESS AND THEIR USE
DE60002554D1 (de) Pyrazino(aza)indolderivate
CY1109722T1 (el) Ενδιαμεσες ενωσεις για την παρασκευη της trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,73oxepino[4,5-c]pyrrole
NO20063748L (no) Kinolinderivater og anvendelse derav som mykobakterielle inhibitorer
TW200716518A (en) Acetylene derivatives
NO20082445L (no) Neuropeptid-2 reseptor-agonister
DE60231414D1 (de) 3-substituierte 4-pyrimidonderivate
NO20082630L (no) Vann-opploslige benzoazepinforbindelser og farmasoytisk forbindelse
US5401844A (en) Regulation of enzymes which utilize tetrahydrobiopterin or tetrahydrofolate cofactors with 6,6-disubstituted-tetrahydropteridines
DE60304726D1 (de) Benzimidazolderivative und ihre verwendung als prodrugs für protonenpumpenhemmer
ATE402175T1 (de) 4-oxo-1-(3-substituiertesphenyl)-1,4-dihydro-1, - naphthyridin-3-carbonsäureamide alsphoshodiesterase-4-inhibitoren
ATE364044T1 (de) 5ht2c rezeptor agonisten zur behandlung von diabetes und fettleibigkeit
JP2007505122A (ja) ニューロン性一酸化窒素シンターゼの複素環式芳香族選択的阻害剤
ATE525371T1 (de) Salze von imidazol-5-carbonsäure-derivaten, herstellungsverfahren und verwendung davon
CA2584195C (fr) Utilisation de derives de purines pour la fabrication de medicaments pour le traitement de la mucoviscidose et de maladies liees a un defaut d'adressage des proteines dans les cellules
WO2003103590A3 (en) HETEROBICYCLIC P38 (HALO-BENZO CARBONYL) KINASE INHIBITORS
Scribner et al. Synthesis and biological activity of anticoccidial agents: 2, 3-diarylindoles
NO20033130D0 (no) 2-amino-4-heteroaryletyltiazolinderivater og deres anvendelse som inhibitorer for inducibel NO-syntase

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application